Welcome, visitor! [ Login

Dragon Announces the Appointment of Board of Directors and Auditor

News

Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG) announced the completion of the Company’s Annual General Meeting held in Vancouver on June 26, 2003. The shareholders have re-elected the following five members of the Board of Directors.

Dr. Alexander Wick, President and Chief Executive Officer

Dr. Longbin Liu, M.D., Chairman of the Board of Directors

Dr. Ken Z. Cai, Ph.D., Director

Dr. Y.K. Sun, M.B., B.S. (HK), Director

Mr. Philip Yuen, Director

Prior to the Annual General Meeting, Mr. Greg Hall, a member of the Board of Directors since 1998, withdrew his nomination as a Director of the Company due to personal reasons. “On behalf of Dragon’s Board of Directors and the management team, I wish to express our sincere appreciation to Mr. Hall for his contribution to the Company. As a director of the Company, Mr. Hall had shared many responsibilities that led to prompt and sound decisions by the Board.” said Dr. Alexander Wick, President and Chief Executive Officer of Dragon.

The Company also announced that shareholders of the Company have ratified the re-appointment of Moore Stephens Ellis Foster Ltd., Chartered Accountants, to audit Dragon’s financial statements for the year ending December 31, 2003.

About Dragon Pharmaceutical Dragon Pharmaceutical Inc. is an international biopharmaceutical company headquartered in Vancouver, Canada, with cGMP production and research and development facilities in Nanjing, China. The Company develops and commercializes human proteins for therapeutic use. Based on its proven protein expression technology, Dragon believes that it has become a competitive producer of Erythropoietin (EPO), a breakthrough drug that has revolutionized the treatment of anemia. Dragon’s EPO is currently approved to treat anemia due to renal failure and surgery in China, India, Brazil, Egypt and Peru. Additional regulatory submissions are in progress throughout Central and Eastern Europe, Asia, Latin America, the Middle East and Africa.

Legal Dragon Pharma

Dragon Pharma provides over the counter and prescription drug pharmacy – Suspension100 On-Line.

No Tags

10 total views, 1 today

  

  • Dragon Pharma Sells Polymun Development

    Dragon Pharmaceutical Inc. (OTC BB: DRUG; TSX: DDD) (“the Company”) announced today that the Company has sold its Development and Manufacturing Agreement with Polymun Scientific Immunbiologische Forschung GmBh (“Polymun”) to AS Biotech AG, a Swiss company, for US$1 million. Prior to the acquisition of Oriental Wave Holding Limited in early 2005, Dragon entered into a […]

  • Dragon Announces Growth in International EPO Sales

    Dragon Pharmaceuticals Inc. (NASDAQ OTC: DRUG) today announced the receipt of EPO sales orders from international markets outside of China totaling $937,500 in the first quarter of 2002, representing a 113% increase over total year international sales of $440,125 in 2001. To date, the Company has completed EPO shipments for $847,500 of first quarter orders, […]

  • Dragon Ships EPO Internationally

    Dragon Pharmaceuticals Inc. (NASDAQ OTC: DRUG) today announced that it has filled orders for recombinant erythropoietin (EPO) from Egypt, India and Peru where, in addition to China, the Company’s EPO is approved for use in the treatment of anemia related to chronic renal failure. All dollar amounts are stated in US dollars. “Penetrating new markets […]

  • Dragon Pharmaceutical Inc. Announces 2002 Fourth Quarter and Full Year Results

    Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG) today announced results for the three-month and twelve-month periods ending December 31, 2002. 2002 Highlights Generated revenues of $7.36 million, representing significant growth from $3.07 million in 2001. Enhancement of gross margin in 2002 to 86.7% from 81% in 2001. Reported a first ever operating profit of […]

  • Dragon Announces Participation at Biopartnering Europe 2001

    Dragon Pharmaceuticals Inc. (OTC BB – DRUG.OB) is pleased to announce that it has been invited to present at the BioPartnering Europe 2001 conference to be held at the Queen Elizabeth II Conference Centre in London, England from October 14th to 16th, 2001. BioPartnering Europe is the premier European venue for showcasing innovative biopharmaceutical and […]

Dragon Pharma Suppliers

dragon pharma source
american steroids online
real dragon pharma supplier
dragon pharma for sale
dragon pharma legit supplier
buy dragon pharma
dragon pharma store
buy steroids
dragon pharma legit dragon pharma anabolics